Titus Gary 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 11, 2013
Insider Transaction Report
Form 4
Titus Gary
Director
Transactions
- Award
Stock Option (right to buy)
2013-03-07−21,945→ 21,945 totalExercise: $2.72Exp: 2020-02-29→ Common Stock (21,945 underlying) - Award
Stock Option (right to buy)
2013-03-07−11,342→ 11,342 totalExercise: $2.72Exp: 2020-02-29→ Common Stock (11,342 underlying)
Footnotes (2)
- [F1]The option vests in equal quarterly installments for four years beginning December 31, 2012.
- [F2]The option vests in equal monthly installments beginning March 1, 2013 and ending on September 1, 2016.